(AGENPARL) – LONDON (UNITED KINGDOM), ven 27 marzo 2020
Veyvondi is indicated in adults (age 18 and older) with von Willebrand Disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or not indicated for the
– Treatment of haemorrhage and surgical bleeding
– Prevention of surgical bleeding.
Veyvondi should not be used in the treatment of Haemophilia A.